piracetam has been researched along with Cardiovascular Stroke in 5 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Influence of litonit and piracetam on development of experimental myocardial infarction, free radical lipid oxidation in myocardium and immunological reactivity was studied in dogs." | 7.67 | [Effects of litonit and piracetam on the course of experimental myocardial infarction]. ( Kadyrova, LL; Kravchenko, LS; Kresiun, VI, 1989) |
| "Piracetam and inosine treatment was associated with the inhibition of free-radical lipid oxidation and a reduction of hypoxia, those being accompanied by increased collagenogenesis and accelerated postinfarction scar formation." | 6.66 | [Stimulation of reparative processes in myocardial infarction: comparative evaluation of the effects of piracetam and inosine]. ( Berestov, AA; Golikov, AP; Karev, VA; Konorev, LA; Polumiskov, VIu, 1988) |
| "Influence of litonit and piracetam on development of experimental myocardial infarction, free radical lipid oxidation in myocardium and immunological reactivity was studied in dogs." | 3.67 | [Effects of litonit and piracetam on the course of experimental myocardial infarction]. ( Kadyrova, LL; Kravchenko, LS; Kresiun, VI, 1989) |
| "Fifty-four patients with acute myocardial infarction were evaluated repeatedly, with 28 of those treated with piracetam, and 26 used as controls." | 3.67 | [Therapeutic use of piracetam in myocardial infarct patients]. ( Fedorov, VS; Leshchinskiĭ, LA; Pimenov, LT, 1987) |
| "Piracetam and inosine treatment was associated with the inhibition of free-radical lipid oxidation and a reduction of hypoxia, those being accompanied by increased collagenogenesis and accelerated postinfarction scar formation." | 2.66 | [Stimulation of reparative processes in myocardial infarction: comparative evaluation of the effects of piracetam and inosine]. ( Berestov, AA; Golikov, AP; Karev, VA; Konorev, LA; Polumiskov, VIu, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riabinin, VA | 1 |
| Golikov, AP | 2 |
| Kresiun, VI | 1 |
| Kravchenko, LS | 1 |
| Kadyrova, LL | 1 |
| Karev, VA | 1 |
| Polumiskov, VIu | 1 |
| Konorev, LA | 1 |
| Berestov, AA | 1 |
| Leshchinskiĭ, LA | 1 |
| Pimenov, LT | 1 |
| Fedorov, VS | 1 |
| Tsorin, IB | 1 |
| Chichkanov, GG | 1 |
2 trials available for piracetam and Cardiovascular Stroke
| Article | Year |
|---|---|
[The effect of various types of stress-limiting therapy on the outcome of myocardial infarction].
Topics: Aged; Antioxidants; Clinical Trials as Topic; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fe | 1990 |
[Stimulation of reparative processes in myocardial infarction: comparative evaluation of the effects of piracetam and inosine].
Topics: Adult; Aged; Animals; Clinical Trials as Topic; Collagen; Drug Evaluation, Preclinical; Female; Free | 1988 |
3 other studies available for piracetam and Cardiovascular Stroke
| Article | Year |
|---|---|
[Effects of litonit and piracetam on the course of experimental myocardial infarction].
Topics: Animals; Dogs; Lipid Peroxidation; Myocardial Infarction; Myocardium; Nicotinic Acids; Piracetam; Py | 1989 |
[Therapeutic use of piracetam in myocardial infarct patients].
Topics: Acute Disease; Analgesics; Angina Pectoris; Blood Pressure; Clinical Enzyme Tests; Coronary Circulat | 1987 |
[Effect of preparations with antihypoxic properties on ischemic damage to the myocardium].
Topics: Animals; Cats; Hypoxia; Male; Myocardial Infarction; Piracetam; Pyridoxine; Rats; Sodium Oxybate | 1986 |